{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T20:22:31Z","timestamp":1750018951324},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to analyze the clinical characteristics and prognostic factors of patients, divided into over 40-year-old group or not, with precursor T-cell lymphoblastic lymphoma (Pre-T-LBL). Based on the retrospective analysis of the clinical data of 59 patients with Pre-T-LBL during the period from December 2010 to December 2015, albumin level, anemia, pleural or pericardial effusion, protocol, therapy response, mediastinal mass, lactate dehydrogenase (LDH), and international prognostic index (IPI) or age-adjusted international prognostic index (aaIPI) were summarized. For patients aged &lt;40 years, factors correlating with poor progression-free survival (PFS) were pleural or pericardial effusion, regimen, albumin level and therapy response. Pleural or pericardial effusion, aaIPI score, regimen, LDH increased, albumin level, therapy response and mediastinal mass were all related with poor overall survival (OS). In the patients aged \u226540 years, only anemia associated with PFS. However, anemia, involvement of bone marrow and therapeutic response were all related with poor OS. In conclusion, the patients with Pre-T-LBL are characterized by a low incidence and bad prognosis. Different prognostic factors can be discovered for patients over 40-year-old with Pre-T-LBL comparing to the youngers. New prognostic evaluation factors should be explored for patients \u226540 years old.<\/jats:p>","DOI":"10.1038\/s41598-018-19565-x","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T12:02:16Z","timestamp":1515758536000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patients over 40 years old with precursor T-cell lymphoblastic lymphoma have different prognostic factors comparing to the youngers"],"prefix":"10.1038","volume":"8","author":[{"given":"Meng","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoxuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mijing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingjiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"19565_CR1","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/PPO.0b013e31826b1232","volume":"18","author":"CA Portell","year":"2012","unstructured":"Portell, C. A. & Sweetenham, J. W. Adult lymphoblastic lymphoma. Cancer Journal 18, 432\u2013438 (2012).","journal-title":"Cancer Journal"},{"key":"19565_CR2","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. blood 127, 2375\u20132390 (2016).","journal-title":"blood"},{"key":"19565_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.critrevonc.2010.12.003","volume":"79","author":"S Cortelazzo","year":"2011","unstructured":"Cortelazzo, S., Ponzoni, M., Ferreri, A. J. & Hoelzer, D. Lymphoblastic lymphoma. Crit Rev Oncol Hematol 79, 330\u2013343 (2011).","journal-title":"Crit Rev Oncol Hematol"},{"key":"19565_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","volume":"27","author":"F Huguet","year":"2009","unstructured":"Huguet, F. et al. Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study. Journal of Clinical Oncology 27, 911\u2013918 (2009).","journal-title":"Journal of Clinical Oncology"},{"key":"19565_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3109\/0284186X.2014.889850","volume":"53","author":"F Ellin","year":"2014","unstructured":"Ellin, F., Jerkeman, M. & Hagberg, H. Treatment outcome in T-cell lymphoblastic lymphoma in adults - a population-based study from the Swedish Lymphoma Registry. Acta oncologica 53, 927\u2013934 (2014).","journal-title":"Acta oncologica"},{"key":"19565_CR6","doi-asserted-by":"publisher","first-page":"38884","DOI":"10.18632\/oncotarget.9144","volume":"7","author":"MY Zhu","year":"2016","unstructured":"Zhu, M. Y. et al. A childhood chemotherapy protocol improves overall survival among adults with T-lymphoblastic lymphoma. Oncotarget 7, 38884\u201338891 (2016).","journal-title":"Oncotarget"},{"key":"19565_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","volume":"144","author":"MJMLJ You","year":"2015","unstructured":"You, M. J. M. L. J. & Hsi, E. D. et al. T-lymphoblastic leukemia\/lymphoma. American journal of clinical pathology 144, 411\u2013422 (2015).","journal-title":"American journal of clinical pathology"},{"key":"19565_CR8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/pbc.20342","volume":"45","author":"MS Cairo","year":"2005","unstructured":"Cairo, M. S., Raetz, E., Lim, M. S., Davenport, V. & Perkins, S. L. Childhood and adolescent non-Hodgkin lymphoma: New insights in biology and critical challenges for the future. Pediatric Blood & Cancer 45, 753\u2013769 (2005).","journal-title":"Pediatric Blood & Cancer"},{"key":"19565_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.critrevonc.2010.12.003","volume":"79","author":"SP Cortelazzo","year":"2011","unstructured":"Cortelazzo, S. P. & M. Ferreri, A. J. et al. Lymphoblastic lymphoma. Crit Rev Oncol Hematol 79, 330\u2013343 (2011).","journal-title":"Crit Rev Oncol Hematol"},{"key":"19565_CR10","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","volume":"99","author":"DG Hoelzer","year":"2002","unstructured":"Hoelzer, D. G. & N. Digel, W. et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 99, 4379\u20134385 (2002).","journal-title":"Blood"},{"key":"19565_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1590\/1806-9282.61.05.417","volume":"61","author":"MC Oliveira","year":"2015","unstructured":"Oliveira, M. C. et al. Outcome of children and adolescents with lymphoblastic lymphoma. Revista da Associacao Medica Brasileira 61, 417\u2013422 (2015).","journal-title":"Revista da Associacao Medica Brasileira"},{"key":"19565_CR12","first-page":"1056","volume":"24","author":"P Yang","year":"2016","unstructured":"Yang, P. et al. [Analysis of Clinical Feature and Curative Efficacy of 30 Patients with T Cell Lymphoblastic Lymphoma]. Zhongguo shi yan xue ye xue za zhi 24, 1056\u20131060 (2016).","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"19565_CR13","first-page":"377","volume":"21","author":"X Jin","year":"2013","unstructured":"Jin, X. et al. Analysis of clinical characteristics and prognostic factors of primary mediastinal T-cell lymphoblastic lymphoma. Zhongguo shi yan xue ye xue za zhi 21, 377\u2013382 (2013).","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"19565_CR14","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ejca.2008.02.011","volume":"44","author":"A Uyttebroeck","year":"2008","unstructured":"Uyttebroeck, A. et al. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial. European journal of cancer 44, 840\u2013846 (2008).","journal-title":"European journal of cancer"},{"key":"19565_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/ajh.24285","volume":"91","author":"MD Seftel","year":"2016","unstructured":"Seftel, M. D. et al. Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission. American journal of hematology 91, 322\u2013329 (2016).","journal-title":"American journal of hematology"},{"key":"19565_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1182\/blood-2014-10-551895","volume":"126","author":"MRF Litzow","year":"2015","unstructured":"Litzow, M. R. F. & A., A. How I treat T-cell acute lymphoblastic leukemia in adults. Blood 126, 833\u2013841 (2015).","journal-title":"Blood"},{"key":"19565_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/leu.2014.229","volume":"29","author":"DJSKE DeAngelo","year":"2015","unstructured":"DeAngelo, D. J. S. K. E. & Dahlberg, S. E. et al. Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia. Leukemia 29, 526\u2013534 (2015).","journal-title":"Leukemia"},{"key":"19565_CR18","doi-asserted-by":"crossref","unstructured":"Ram, R. et al. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: Systematic review and meta-analysis. Am J Hematol 87, 472\u2013478 (2012).","DOI":"10.1002\/ajh.23149"},{"key":"19565_CR19","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1200\/JCO.2007.13.7265","volume":"26","author":"Ribera","year":"2008","unstructured":"Ribera et al. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanol de Tratamiento en Hematologia pediatric-based protocol ALL-96. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 26, 1843\u20131849 (2008).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"19565_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00277-015-2510-0","volume":"95","author":"S Kako","year":"2015","unstructured":"Kako, S. et al. Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, l-asparaginase, and\/or methotrexate may improve the outcome of T-lineage ALL. Annals of hematology 95, 87\u201392 (2015).","journal-title":"Annals of hematology"},{"key":"19565_CR21","doi-asserted-by":"crossref","unstructured":"Richard, N. P. et al. Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia. (2016).","DOI":"10.18632\/oncotarget.12394"},{"key":"19565_CR22","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1182\/blood-2016-02-698936","volume":"128","author":"H Miyoshi","year":"2016","unstructured":"Miyoshi, H. et al. PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia\/lymphoma. Blood 128, 1374\u20131381 (2016).","journal-title":"Blood"},{"key":"19565_CR23","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1182\/blood-2012-12-474148","volume":"121","author":"BR Bonn","year":"2013","unstructured":"Bonn, B. R. et al. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. Blood 121, 3153\u20133160 (2013).","journal-title":"Blood"},{"key":"19565_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/leu.2015.202","volume":"30","author":"AML-N Roncero","year":"2016","unstructured":"Roncero, A. M. L.-N. & P.Cobos-Fernandez, M. A. et al. Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development. Leukemia 30, 94\u2013103 (2016).","journal-title":"Leukemia"},{"key":"19565_CR25","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/leu.2015.203","volume":"30","author":"STM Balbach","year":"2016","unstructured":"Balbach, S. T. M. & O. Bonn, B. R. et al. Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia. Leukemia 30, 970\u2013973 (2016).","journal-title":"Leukemia"},{"key":"19565_CR26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/gcc.20924","volume":"50","author":"K Basso","year":"2011","unstructured":"Basso, K. et al. T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses. Genes, chromosomes & cancer 50, 1063\u20131075 (2011).","journal-title":"Genes, chromosomes & cancer"},{"key":"19565_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/pbc.20550","volume":"47","author":"EA Raetz","year":"2006","unstructured":"Raetz, E. A. et al. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer 47, 130\u2013140 (2006).","journal-title":"Pediatr Blood Cancer"},{"key":"19565_CR28","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"D Bruce","year":"1999","unstructured":"Bruce, D. & Cheson, S. Jea Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin\u2019s Lymphomas. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 17, 1244\u20131253 (1999).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19565-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:03:38Z","timestamp":1671584618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19565-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19565"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19565-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,18]]},"assertion":[{"value":"6 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1088"}}